Florida Senate - 2023 SB 612
By Senator Yarborough
4-00814-23 2023612__
1 A bill to be entitled
2 An act relating to the prevention of blood clots;
3 providing a short title; requiring the Agency for
4 Health Care Administration, in conjunction with the
5 Department of Health, to establish a blood clot and
6 pulmonary embolism prevention policy workgroup;
7 providing for membership, meetings, and duties of the
8 workgroup; requiring the agency to submit a certain
9 report to the Governor and the Legislature by a
10 specified date; requiring the agency to submit a final
11 report on the workgroup’s findings and recommendations
12 by a specified date; providing for expiration of the
13 workgroup; providing an effective date.
14
15 Be It Enacted by the Legislature of the State of Florida:
16
17 Section 1. This act may be cited as the “Emily Adkins Blood
18 Clot Prevention Act.”
19 Section 2. (1) The Agency for Health Care Administration,
20 in conjunction with the Department of Health, shall establish a
21 blood clot and pulmonary embolism prevention policy workgroup.
22 (2)(a) The workgroup shall be composed of the following
23 members:
24 1. Four members representing state-licensed health care
25 facilities, appointed by the Secretary of Health Care
26 Administration.
27 2. Four members representing state-licensed health care
28 providers, appointed by the State Surgeon General. The Surgeon
29 General shall select one of his or her appointees to serve as
30 chair of the workgroup.
31 3. Five members representing patients who have experienced
32 blood clots, family members of patients who have died from blood
33 clots, advocates for blood clot and pulmonary embolism
34 prevention policies, health care associations, and other
35 interested parties or associations, appointed by the Governor.
36 4. Two members appointed by the President of the Senate.
37 5. Two members appointed by the Speaker of the House of
38 Representatives.
39 (b) Members of the workgroup shall serve at their own
40 expense and are not entitled to receive compensation or
41 reimbursement for per diem or travel expenses.
42 (c) The workgroup shall meet at the call of the chair and
43 may conduct its meetings through teleconference or other
44 electronic means.
45 (d) The chair may create subcommittees to help with
46 gathering research, scheduling speakers on relevant subjects,
47 and drafting workgroup reports and policy recommendations.
48 (3) The workgroup shall do all of the following, at a
49 minimum:
50 (a) Identify the aggregate number of people who experience
51 blood clots and pulmonary embolisms each year in this state.
52 (b) Identify how data is collected in this state regarding
53 blood clots, pulmonary embolisms, and adverse health outcomes
54 associated with these conditions.
55 (c) Identify how blood clots and pulmonary embolisms impact
56 the lives of residents in this state.
57 (d) Identify the best practices and standards of care for
58 blood clot surveillance, detection, and treatment.
59 (e) Identify emerging treatments, therapies, and research
60 relating to blood clots and pulmonary embolisms.
61 (f) Develop a risk surveillance system to help health care
62 providers identify patients who may be at higher risk for blood
63 clots or pulmonary embolisms.
64 (g) Develop policy recommendations to help improve patient
65 awareness of blood clot risks.
66 (h) Develop policy recommendations to help health care
67 facilities, including, but not limited to, hospitals, ambulatory
68 surgical centers, nursing homes, assisted living facilities, and
69 residential treatment facilities, improve surveillance and
70 detection of patients who may be at a higher risk for blood
71 clots or pulmonary embolisms.
72 (i) Develop recommended guidelines for the standard of care
73 for patients at risk for blood clots or pulmonary embolisms.
74 (j) Develop recommended literature relating to increased
75 risks of blood clots which health care facilities and health
76 care providers can provide to patients and their families.
77 (4) By January 31, 2024, the Agency for Health Care
78 Administration shall submit a report to the Governor, the
79 President of the Senate, and the Speaker of the House of
80 Representatives which provides an update on the workgroup’s
81 activities, findings, and recommendations. The agency shall
82 submit a final report on all of the workgroup’s findings and
83 recommendations by January 31, 2025.
84 (5) This section expires February 1, 2025.
85 Section 3. This act shall take effect upon becoming a law.